[PERSON]
Mick Farrell
Featured in 5 tracked stories · first seen
Situations
ResMed quarterly financial performance
2 clusters · 5 sources · last updated
Latest: ResMed reports strong quarterly earnings and dividend
ResMed reported strong financial results for the third quarter of 2026, with revenue reaching $1.41 billion. This figure represented a 5.9% year-on-year increase and exceeded analyst consensus estimates of $1.39 billion.
Also covered in
-
ResMed targets 12% to 14% EPS growth amid rising sleep therapy demand
[BUSINESS] · 2 sources ·